BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28632393)

  • 1. The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.
    Hsu HC; Tong S; Zhou Y; Elmes MW; Yan S; Kaczocha M; Deutsch DG; Rizzo RC; Ojima I; Li H
    Biochemistry; 2017 Jul; 56(27):3454-3462. PubMed ID: 28632393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.
    Yan S; Elmes MW; Tong S; Hu K; Awwa M; Teng GYH; Jing Y; Freitag M; Gan Q; Clement T; Wei L; Sweeney JM; Joseph OM; Che J; Carbonetti GS; Wang L; Bogdan DM; Falcone J; Smietalo N; Zhou Y; Ralph B; Hsu HC; Li H; Rizzo RC; Deutsch DG; Kaczocha M; Ojima I
    Eur J Med Chem; 2018 Jun; 154():233-252. PubMed ID: 29803996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses.
    Chen J; Liu X; Zhang S; Chen J; Sun H; Zhang L; Zhang Q
    Phys Chem Chem Phys; 2020 Jan; 22(4):2262-2275. PubMed ID: 31917380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening.
    Zhou Y; Elmes MW; Sweeney JM; Joseph OM; Che J; Hsu HC; Li H; Deutsch DG; Ojima I; Kaczocha M; Rizzo RC
    Biochemistry; 2019 Oct; 58(42):4304-4316. PubMed ID: 31539229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs.
    Berger WT; Ralph BP; Kaczocha M; Sun J; Balius TE; Rizzo RC; Haj-Dahmane S; Ojima I; Deutsch DG
    PLoS One; 2012; 7(12):e50968. PubMed ID: 23236415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents.
    Wang H; Taouil A; Awwa M; Clement T; Zhu C; Kim J; Rendina D; Jayanetti K; Maharaj A; Wang L; Bogdan D; Pepe A; Kaczocha M; Ojima I
    Bioorg Chem; 2022 Dec; 129():106184. PubMed ID: 36244323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia.
    Kaczocha M; Rebecchi MJ; Ralph BP; Teng YH; Berger WT; Galbavy W; Elmes MW; Glaser ST; Wang L; Rizzo RC; Deutsch DG; Ojima I
    PLoS One; 2014; 9(4):e94200. PubMed ID: 24705380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.
    Peng X; Studholme K; Kanjiya MP; Luk J; Bogdan D; Elmes MW; Carbonetti G; Tong S; Gary Teng YH; Rizzo RC; Li H; Deutsch DG; Ojima I; Rebecchi MJ; Puopolo M; Kaczocha M
    Mol Pain; 2017 Jan; 13():1744806917697007. PubMed ID: 28326944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
    Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
    BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human brain-type fatty acid-binding protein FABP7 complexed with palmitic acid.
    Nam KH
    Acta Crystallogr D Struct Biol; 2021 Jul; 77(Pt 7):954-965. PubMed ID: 34196621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies.
    Shimamoto C; Ohnishi T; Maekawa M; Watanabe A; Ohba H; Arai R; Iwayama Y; Hisano Y; Toyota T; Toyoshima M; Suzuki K; Shirayama Y; Nakamura K; Mori N; Owada Y; Kobayashi T; Yoshikawa T
    Hum Mol Genet; 2014 Dec; 23(24):6495-511. PubMed ID: 25027319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truxillic acid monoamides as fatty acid binding protein 5 inhibitors.
    Zhu C; Schutz L; Jayanetti K; Takemura K; Doswell F; Wang L; Ojima I; Kaczocha M
    Bioorg Med Chem; 2023 Oct; 94():117464. PubMed ID: 37708641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined computational-biophysical approach to understanding fatty acid binding to FABP7.
    Bodnariuc I; Lenz S; Renaud-Young M; Butler TM; Ishida H; Vogel HJ; MacCallum JL
    Biophys J; 2023 Mar; 122(5):741-752. PubMed ID: 36751130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Fabp7 and Fabp5 on postnatal hippocampal neurogenesis in the mouse.
    Matsumata M; Sakayori N; Maekawa M; Owada Y; Yoshikawa T; Osumi N
    Stem Cells; 2012 Jul; 30(7):1532-43. PubMed ID: 22581784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
    Al-Jameel W; Gou X; Forootan SS; Al Fayi MS; Rudland PS; Forootan FS; Zhang J; Cornford PA; Hussain SA; Ke Y
    Oncotarget; 2017 May; 8(19):31041-31056. PubMed ID: 28415688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of
    Wang W; Liu Z; Chen X; Lu Y; Wang B; Li F; Lu S; Zhou X
    DNA Cell Biol; 2021 Aug; 40(8):1076-1086. PubMed ID: 34160301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid-binding proteins 5 and 7 gene deletion increases sucrose consumption and diminishes forced swim immobility time.
    Hamilton J; Koumas C; Clavin BH; Marion M; Figueiredo A; Gonzalez S; O'Rourke JR; Deutsch D; Kaczocha M; Haj-Dahmane S; Thanos PK
    Behav Pharmacol; 2018 Sep; 29(6):503-508. PubMed ID: 29570114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5.
    Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway.
    Lei Q; Yu Z; Li H; Cheng J; Wang Y
    J Adv Res; 2022 Sep; 40():197-206. PubMed ID: 36100327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
    Sharifi K; Ebrahimi M; Kagawa Y; Islam A; Tuerxun T; Yasumoto Y; Hara T; Yamamoto Y; Miyazaki H; Tokuda N; Yoshikawa T; Owada Y
    Cell Tissue Res; 2013 Dec; 354(3):683-95. PubMed ID: 24114376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.